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Case Report
Conventional Epi-LASIK and Lamellar Epithelial 
Debridement in Myopic Patients with Dermatologic Keloids
Jun Yong Lee, Dong Ju Youm, Chul Young Choi
Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
We report the outcome of conventional epipolis laser in situ keratomileusis (Epi-LASIK, flap-on) and lamellar epi-
thelial debridement (LED; Epi-LASIK, flap-off) in myopic patients with dermatologic keloids. Three patients, who 
were all noted to be susceptible to keloid scarring, received conventional Epi-LASIK in their right eyes and LED in 
their left eyes. The patients were followed-up for 6 to 21 months after their surgeries, and the outcomes were then 
evaluated. In case 1, the preoperative spherical equivalent (SE) was -6.5 diopters (D) in the right eye (OD) and -6.25 
D in the left eye (OS). At 21 months postoperatively, the uncorrected visual acuity (UCVA) was 20 / 12.5 in both 
eyes. In case 2, the preoperative SE was -5.25 (OD) / -6.00 (OS). After six months, the postoperative UCVA was 20 
/ 12.5 in both eyes. In case 3, the preoperative SE was -4.5 (OD) / -2.0 (OS). The UCVA at the six-month follow-up 
was 20 / 12.5 in both eyes. No adverse events, including corneal haze, occurred in any of the patients. All three of 
our patients reported excellent visual outcomes following both conventional Epi-LASIK and LED, despite their his-
tories of keloid formation. The present cases suggest that both Epi-LASIK and LED may be safe and effective tech-
niques for myopic patients with dermatologic keloids.
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A keloid is a hyperproliferative growth of dense fibrous 
tissue that occurs beyond the borders of a wound due to an 
abnormal healing response to a cutaneous injury [1]. The re-
sults of photorefractive keratectomy (PRK) or laser in situ 
keratomileusis (LASIK) in patients with dermatologic ke-
loids have been contradictory and could potentially be mis-
leading [2-5]. Epipolis (Epi)-LASIK is an alternative surface 
ablation procedure for refractive surgery [6]. In conventional 
Epi-LASIK (flap-on), the epithelial sheet is repositioned on 
the stroma after ablation. Whereas, lamellar epithelial de-
bridement (LED; Epi-LASIK, flap-off) is a modified surface 
ablation that results in complete removal of the epithelial flap 
[7].
To the best of our knowledge, neither the healing response 
nor the visual and refractive outcomes of conventional Epi- 
LASIK or LED in patients with keloids have been reported 
previously. In this report, we describe the outcomes of con-
ventional Epi-LASIK and LED in myopic patients with der-
matologic keloids that were confirmed via dermatological 
consultations.
Case Reports
Surgical procedure
 Each of the three patients in this study simultaneously re-
ceived conventional Epi-LASIK in the right eye and LED in 
the left eye. An epithelial flap was created in both eyes using 
the Amadeus II (AMO Inc., Santa Ana, CA, USA). We used 
a blade oscillation speed of 11,000 rpm, a translation speed of 
1.5 mm per second, and a vacuum pressure of 800 mmHg, 
which resulted in 9.0 mm epithelial flaps. The laser treatment 
was performed using an excimer laser (VISX Star S4; VISX 
Inc., Santa Clara, CA, USA). After ablation, the epithelial 
flap was repositioned on the stroma in the right eye and was 
removed from the left eye. A soft contact lens (Focus, Ciba 
Vision, Duluth, GA, USA; B.C 8.8 mm, Ф 12.0 mm) was 
placed onto the eyes at the end of the procedure. In this series 
of surgeries on a total of six eyes of three patients, the sur-
geries were performed uneventfully without any epithelial 
problems. JY Lee, et al. Epi-LASIK and LED in Patients with Keloids
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Table 1. Preoperative characteristics and demographics
Age (yr) Sex
Preoperative SE (diopters) Pachymetry (mirocometers)
OD OS OD OS
Case 1 25 Female -6.5 -6.25 612 610
Case 2 28 Female -5.25 -6 606 603
Case 3 32 Female -4.5 -2 639 604
SE = spherical equivalent; OD = right eye; OS = left eye.
A  B
OD OS
Fig. 1. Photographs of a 28-year-old woman (case 2). (A) Keloid scar on the left shoulder. (B) No subepithelial corneal haze in either eye at 
six months postoperatively. OD = right eye; OS = left eye.
Postoperative care
Moxifloxacin 0.5% (Vigamox; Alcon, Fort Worth, TX, 
USA) and prednisolone acetate 1% (Pred Forte; Allergan, 
Westport, Ireland) eye drops were used every six hours for 
the first week after surgery. After the first week, 0.1% fluo-
rometholone (Ocumetholone; Samil, Seoul, Korea) was ad-
ministered four times daily for the first month, twice daily for 
the following month, and once a day for the third month. 
Routine postoperative examinations were scheduled at 1 day, 
3 days, 1 week, 1 month, 3 months and 6 months from the 
surgery date.
Case 1
A 25-year-old woman was evaluated for refractive surgery. 
She was noted to be susceptible to keloid scarring, as demon-
strated by the presence of scars on both ears. Preoperative 
best-corrected visual acuity (BCVA) was 20 / 16 in both eyes. 
Preoperative spherical equivalent (SE) was -6.5 diopters (D) 
in the right eye (OD) and -6.25 D in the left eye (OS). Ophthalmic 
examination was unremarkable except for moderate myopia. 
Preoperative characteristics and demographics are shown in 
Table 1.
The uncorrected visual acuity (UCVA) was 20 / 32 (OD) 
and 20 / 20 (OS) one day postoperatively. At 3 days, 1 week, 
1 month, 3 months, and 6 months postoperatively, the UCVA 
was 20 / 100, 20 / 20, 20 / 20, 20 / 12.5 and 20 / 12.5 (OD) and 
20 / 20, 20 / 20, 20 / 16, 20 / 12.5, and 20 / 12.5 (OS), 
respectively. The patient was invited to a re-examination 21 
months after the surgery, when the SE was -0.125 D (OD) 
and -0.25 D (OS). No adverse events, including corneal haze, 
were observed in this patient, and her visual acuity remained 
at 20 / 12.5 in both eyes.
Case 2
A 28-year-old woman was examined for refractive surgery. 
Her general history revealed a tendency to form keloids, as 
demonstrated by a scar on her left shoulder (Fig. 1A). 
Preoperative BCVA was 20/16 in both eyes, and preoperative 
SE was -5.25 D (OD) and -6.00 D (OS). Ophthalmic exami-
nation was normal except for moderate myopia. Preoperative 
characteristics and demographics are shown in Table 1. 
One day postoperatively, the UCVA was 20 / 25 in both 
eyes. At 3 days, 1 week, 1 month, 3 months, and 6 months 
postoperatively, the UCVA was 20 / 20, 20 / 20, 20 / 16, 20 / 
12.5, and 20 / 12.5 (OD) and 20 / 25, 20 / 20, 20 / 16, 20 / 
12.5, and 20 / 12.5 (OS), respectively. At her final examina-
tion, the SE was -0.50 D (OD) and -0.25 D (OS). There were 
no postoperative complications such as corneal haze (Fig. 1B).
Case 3
A woman 32 years of age was referred for refractive 
surgery. She had a tendency for keloids, which was indicated 
by the existence of an over-exuberant scar on her lower abdo-
men (Fig. 2A). Preoperative BCVA was 20/16 in both eyes. 
Preoperative SE was -4.50 D (OD) and -2.00 D (OS). Her 
ophthalmic examination was normal except for mild to mod-
erate myopia. Preoperative characteristics and demographics 
are shown in Table 1.
One day postoperatively, the UCVA was 20 / 50 (OD) and 
20/40 (OS). At 3 days, 1 week, 1 month, 3 months and 6 Korean J Ophthalmol Vol.25, No.3, 2011
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Fig. 2. Photographs of a 32-year-old woman (case 3). (A) Hypertrophied exuberant scar on the lower abdomen. (B) At 
six months after the surgery, no abnormal findings were observed in either eye. OD = right eye; OS = left eye.
months postoperatively, the UCVA was 20 / 40, 20 / 25, 20 / 
20, 20 / 12.5 and 20 / 12.5 (OD) and 20 / 32, 20 / 25, 20 / 20, 
20 / 12.5 and 20 / 12.5 (OS), respectively. At the final fol-
low-up, the SE was -0.25 D (OD) and -0.50 D (OS), and no 
postoperative adverse events occurred (Fig. 2B).
Discussion
Both PRK and LASIK have been shown to be predictable 
and safe methods for the treatment of low to moderate re-
fractive errors. There is, however, no consensus on the safety 
and efficacy guidelines of PRK or LASIK for patients with 
dermatologic keloids. Tanzer et al. [2] have reported that a 
history of keloid formation does not appear to adversely af-
fect the outcomes of PRK. Similarly, Cobo-Soriano et al. [3] 
reported no difference in the anatomical or functional results 
following LASIK between patients with dermatologic ke-
loids and those without. In addition, Artola et al. [4] concluded 
that LASIK is a predictably safe and effective technique for 
myopic patients with dermatologic keloids. However, Girgis 
et al. [5] reported significant corneal haze after LASIK and 
PRK in a Caucasian patient with a history of dermatologic 
keloids. The United States Food and Drug Administration al-
so requires the labeling of excimer lasers that are approved 
for PRK and LASIK to include any history of keloid for-
mation as a relative contraindication to laser refractive surgery.
Keloids are characterized by the uncontrolled synthesis 
and excessive deposition of collagen and glycoproteins. It 
has been suggested that keloid keratinocytes play an im-
portant role in keloidogenesis by influencing fibroblasts. 
Keratinocytes may promote proliferation and oppose the 
apoptosis of fibroblasts though paracrine effects such as in-
creased expression of the transforming growth factor (TGF)-
β [8,9]. Similar to keloidogenesis, cytokines and growth fac-
tors such as TGF-β1 are released into the tear film by the lac-
rimal gland after corneal epithelial injury [10]. During the re-
generation of the epithelium after refractive surgery, these 
cytokines and growth factors from the tear fluid may pene-
trate the corneal stroma, which may potentially activate stro-
mal keratocytes. Theoretically, the activated keratocytes at 
the borders of the ablation zone may transform into myofi-
broblasts, which may in turn migrate into the subepithelial 
space and result in corneal haze [11].
Pallikaris et al. [6] have described an alternative for epi-
thelial separation using an instrument called an epikeratome. 
The epithelial sheet is repositioned on the stroma after abla-
tion in conventional Epi-LASIK and is removed from the 
stroma in LED [7]. Katsanevaki et al. [12] inspected epi-
thelial flaps that were harvested 24 hours after they were ac-
cidentally dislocated during the Epi-LASIK procedure and 
found that most epithelial cells were morphologically normal 
with only minor cell degeneration. Since relatively minor 
corneal epithelial injury typically occurs in Epi-LASIK and 
LED, fewer cytokines and growth factors such as TGF-β1 
may be released into the tear film. In support of this, Long et 
al. [13] reported that TGF-β1 levels are lower in the tear fluid 
measured after the Epi-LASIK procedure compared to that 
after the LASEK procedure. Therefore, the risk of corneal 
haze or keloid formation after refractive surgery may be low-
er in Epi-LASIK and LED than in PRK and LASIK. In the JY Lee, et al. Epi-LASIK and LED in Patients with Keloids
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present study, the patients, who underwent conventional 
Epi-LASIK in the right eyes and LED in the left eyes, ex-
hibited significant improvement in UCVA, BCVA, and SE 
refraction along with an absence of postoperative adverse 
events. 
Recent studies of keloids suggest that the stretching ten-
sion of the body surface is also an important condition that is 
associated with keloid generation [8,14]. Al-Attar et al. [8] 
reported that the mechanical tension that is placed on the 
healing wound drives fibroblast proliferation and collagen 
synthesis. Akaishi et al. [14] proposed that adhesion with the 
subcutaneous bone structures greatly increased the tension 
applied to the keloid. The lack of significant stretching ten-
sion and underlying hard tissues in the cornea, therefore, 
might contribute to the favorable outcomes of no corneal 
haze in these cases.
In conclusion, all of our patients, who had a tendency to 
form dermatologic keloids, had excellent visual outcomes 
following conventional Epi-LASIK and LED, showing that 
it is possible to perform these procedures safely and effec-
tively in patients with keloids. Further investigation with 
more keloid patients may expand upon the promising results 
seen in this study.
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